NINA LEONARD: Open Payments
NPI 1679877526 · SAINT MARYS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,621 in 93 payments from 14 companies in 2025. Trend: 2023 $1,412 · 2024 $1,039 · 2025 $1,621
Food & beverage: $1,621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $310 |
| Lundbeck LLC | 14 | $302 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $288 |
| Vanda Pharmaceuticals Inc. | 10 | $164 |
| Supernus Pharmaceuticals, Inc. | 8 | $134 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $99 |
| Axsome Therapeutics, Inc. | 5 | $91 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Almatica Pharma LLC | 2 | $40 |
Products named: REXULTI, VRAYLAR, TRINTELLIX, FANAPT, Qelbree, CAPLYTA, Auvelity, COBENFY.
Industry payments across GA — which companies pay providers there.
